167 related articles for article (PubMed ID: 34893067)
1. In vivo alterations of mitochondrial activity and amyloidosis in early-stage senescence-accelerated mice: a positron emission tomography study.
Yamagishi S; Iga Y; Ikegaya S; Kakiuchi T; Ohba H; Nishiyama S; Fukomoto D; Kanazawa M; Harada N; Tsukada H; Sato K; Ouchi Y
J Neuroinflammation; 2021 Dec; 18(1):288. PubMed ID: 34893067
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study.
Yamagishi S; Iga Y; Nakamura M; Takizawa C; Fukumoto D; Kakiuchi T; Nishiyama S; Ohba H; Tsukada H; Sato K; Ouchi Y
J Neuroinflammation; 2019 Nov; 16(1):208. PubMed ID: 31707986
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial complex I abnormalities underlie neurodegeneration and cognitive decline in Alzheimer's disease.
Terada T; Therriault J; Kang MS; Savard M; Pascoal TA; Lussier F; Tissot C; Wang YT; Benedet A; Poltronetti NM; Ottoy J; Arias JF; Bezgin G; Matsudaira T; Bunai T; Obi T; Tsukada H; Ouchi Y; Rosa-Neto P
Eur J Neurol; 2022 May; 29(5):1324-1334. PubMed ID: 35007366
[TBL] [Abstract][Full Text] [Related]
4. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.
Förster S; Yousefi BH; Wester HJ; Klupp E; Rominger A; Förstl H; Kurz A; Grimmer T; Drzezga A
Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1927-36. PubMed ID: 22926714
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer's disease.
Terada T; Therriault J; Kang MSP; Savard M; Pascoal TA; Lussier F; Tissot C; Wang YT; Benedet A; Matsudaira T; Bunai T; Obi T; Tsukada H; Ouchi Y; Rosa-Neto P
Mol Neurodegener; 2021 Apr; 16(1):28. PubMed ID: 33902654
[TBL] [Abstract][Full Text] [Related]
6. Head-to-head comparison of 11C-PiB and 18F-FC119S for Aβ imaging in healthy subjects, mild cognitive impairment patients, and Alzheimer's disease patients.
Byun BH; Kim BI; Park SY; Ko IO; Lee KC; Kim KM; Kim YK; Lee JY; Bu SH; Kim JH; Chi DY; Ha JH; Lim SM
Medicine (Baltimore); 2017 Mar; 96(12):e6441. PubMed ID: 28328855
[TBL] [Abstract][Full Text] [Related]
7. Comparing amyloid-β deposition, neuroinflammation, glucose metabolism, and mitochondrial complex I activity in brain: a PET study in aged monkeys.
Tsukada H; Nishiyama S; Ohba H; Kanazawa M; Kakiuchi T; Harada N
Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2127-36. PubMed ID: 24919653
[TBL] [Abstract][Full Text] [Related]
8. In vivo mitochondrial and glycolytic impairments in patients with Alzheimer disease.
Terada T; Obi T; Bunai T; Matsudaira T; Yoshikawa E; Ando I; Futatsubashi M; Tsukada H; Ouchi Y
Neurology; 2020 Apr; 94(15):e1592-e1604. PubMed ID: 32139504
[TBL] [Abstract][Full Text] [Related]
9. Preclinical and clinical study on [
Xu M; Guo J; Gu J; Zhang L; Liu Z; Ding L; Fu H; Ma Y; Liang S; Wang H
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):652-663. PubMed ID: 34292345
[TBL] [Abstract][Full Text] [Related]
10. Novel PET probes 18F-BCPP-EF and 18F-BCPP-BF for mitochondrial complex I: a PET study in comparison with 18F-BMS-747158-02 in rat brain.
Tsukada H; Nishiyama S; Fukumoto D; Kanazawa M; Harada N
J Nucl Med; 2014 Mar; 55(3):473-80. PubMed ID: 24470629
[TBL] [Abstract][Full Text] [Related]
11. Comparing α7 nicotinic acetylcholine receptor binding, amyloid-β deposition, and mitochondria complex-I function in living brain: A PET study in aged monkeys.
Nishiyama S; Ohba H; Kanazawa M; Kakiuchi T; Tsukada H
Synapse; 2015 Oct; 69(10):475-83. PubMed ID: 26234533
[TBL] [Abstract][Full Text] [Related]
12. Elucidation of the mechanism of changes in the antioxidant function with the aging in the liver of the senescence-accelerated mouse P10 (SAMP10).
Kawahara T; Kita T; Ueno Y; Yamasaki S; Kimura G; Nakanishi M; Hosokawa T; Kurasaki M; Sikder T; Saito T
Exp Gerontol; 2018 Jun; 106():46-53. PubMed ID: 29477336
[TBL] [Abstract][Full Text] [Related]
13. Regional correlations between [
Seo SW; Ayakta N; Grinberg LT; Villeneuve S; Lehmann M; Reed B; DeCarli C; Miller BL; Rosen HJ; Boxer AL; O'Neil JP; Jin LW; Seeley WW; Jagust WJ; Rabinovici GD
Neuroimage Clin; 2017; 13():130-137. PubMed ID: 27981028
[TBL] [Abstract][Full Text] [Related]
14. Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study.
Brendel M; Probst F; Jaworska A; Overhoff F; Korzhova V; Albert NL; Beck R; Lindner S; Gildehaus FJ; Baumann K; Bartenstein P; Kleinberger G; Haass C; Herms J; Rominger A
J Nucl Med; 2016 Jun; 57(6):954-60. PubMed ID: 26912428
[TBL] [Abstract][Full Text] [Related]
15. Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases.
Biechele G; Franzmeier N; Blume T; Ewers M; Luque JM; Eckenweber F; Sacher C; Beyer L; Ruch-Rubinstein F; Lindner S; Gildehaus FJ; von Ungern-Sternberg B; Cumming P; Bartenstein P; Rominger A; Höglinger GU; Herms J; Brendel M
J Neuroinflammation; 2020 Dec; 17(1):374. PubMed ID: 33317543
[TBL] [Abstract][Full Text] [Related]
16. PET imaging of ischemia-induced impairment of mitochondrial complex I function in monkey brain.
Tsukada H; Ohba H; Nishiyama S; Kanazawa M; Kakiuchi T; Harada N
J Cereb Blood Flow Metab; 2014 Apr; 34(4):708-14. PubMed ID: 24447952
[TBL] [Abstract][Full Text] [Related]
17. Development of novel PET probes, [18F]BCPP-EF, [18F]BCPP-BF, and [11C]BCPP-EM for mitochondrial complex 1 imaging in the living brain.
Harada N; Nishiyama S; Kanazawa M; Tsukada H
J Labelled Comp Radiopharm; 2013 Sep; 56(11):553-61. PubMed ID: 24285187
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease.
Snellman A; López-Picón FR; Rokka J; Salmona M; Forloni G; Scheinin M; Solin O; Rinne JO; Haaparanta-Solin M
J Nucl Med; 2013 Aug; 54(8):1434-41. PubMed ID: 23833271
[TBL] [Abstract][Full Text] [Related]
19. Selective worsening of brain injury biomarker abnormalities in cognitively normal elderly persons with β-amyloidosis.
Knopman DS; Jack CR; Wiste HJ; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
JAMA Neurol; 2013 Aug; 70(8):1030-8. PubMed ID: 23797806
[TBL] [Abstract][Full Text] [Related]
20. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.
Klunk WE; Lopresti BJ; Ikonomovic MD; Lefterov IM; Koldamova RP; Abrahamson EE; Debnath ML; Holt DP; Huang GF; Shao L; DeKosky ST; Price JC; Mathis CA
J Neurosci; 2005 Nov; 25(46):10598-606. PubMed ID: 16291932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
